🇺🇸 FDA
Patent

US 6586413

Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists

expired A61KA61K31/00A61K31/7076

Quick answer

US patent 6586413 (Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
73
CPC classes
A61K, A61K31/00, A61K31/7076, A61K45/06, A61K47/55